EPO: Applicant is responsible for checking patent text

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO: Applicant is responsible for checking patent text

Pursuant to Rule 71(3) of the European Patent Convention (EPC), towards the termination of the examination proceedings, the Examining Division of the European Patent Office (EPO) shall inform the applicant of the text in which it intends to grant the European patent. Following Rule 71(5) EPC, if the applicant subsequently pays the grant and publishing fees and files the required translations of the claims, he shall be deemed to have approved the text intended for grant.

In examination proceedings pertaining to EP 2 396 848, in the communication under Rule 71(3) EPC, the Examining Division made reference to the claims submitted by the applicant in the list of documents intended for grant. However, the EPO had left out parts of the claims from the text intended for grant itself. The applicant apparently overlooked the flaw and proceeded by complying with the provisions of Rule 71 EPC, and the patent was subsequently granted in a form from which parts of the claims were missing.

Following the issue of the printed patent, the B1 publication, the applicant requested correction under either one of Rules 139 or 140 EPC, correction of a purported printing error, or that the decision to grant the patent be considered null and void. Neither the Examining Division nor the Board of Appeal allowed either of these requests. In its decision T 506/16, the Board of Appeal notes that:

  • Rule 140 EPC is not available for correcting patents in accordance with Enlarged Board of Appeal decision G 1/10.

  • Rule 139 EPC is only applicable to documents filed with the EPO, i.e. not to documents produced by the EPO.

  • The obligation to check the text in which the patent will be granted lies with the applicant.

  • The decision to grant did not infringe the principle of good faith and the protection of the legitimate expectations of the users of the EPO.

The applicant's attempt to reinstate the missing parts of the claims did not thus succeed, despite the fact that it was the EPO's Examining Division that included an incomplete set of claims in the text intended for grant.

farrington.jpg

Jakob Pade Frederiksen


Inspicos P/SKogle Allé 2DK-2970 HoersholmCopenhagen, DenmarkTel: +45 7070 2422Fax: +45 7070 2423info@inspicos.comwww.inspicos.com

more from across site and SHARED ros bottom lb

More from across our site

Inès Garlantezec, who became principal of the firm’s Luxembourg office earlier this year, discusses what's been keeping her busy, including settling a long-running case
In the sixth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Futures, a network for early-career stage IP professionals
Rachel Cohen has reunited with her former colleagues to strengthen Weil’s IP litigation and strategy work
McKool Smith’s Jennifer Truelove explains how a joint effort between her firm and Irell & Manella secured a win for their client against Samsung
Tilleke & Gibbins topped the leaderboard with four awards across the region, while Anand & Anand and Kim & Chang emerged as outstanding domestic firms
News of a new addition to Via LA’s Qi wireless charging patent pool, and potential fee increases at the UKIPO were also among the top talking points
The keenly awaited ruling should act as a ‘call to arms’ for a much-needed evolution of UK copyright law, says Rebecca Newman at Addleshaw Goddard
Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Gift this article